INDBInternet News Database 2.5 Updated 1 min ago · 393 sources Show or hide images Light or dark

Capricor's Duchenne treatment fails to get FDA approval, shares sink

Save Like Comments Compare coverage

Summary

Capricor's Duchenne treatment fails to get FDA approval, shares sink Reuters

Description from Reuters.

Who is covering this

  1. Reuters Center Factuality: Very high GB
    Capricor's Duchenne treatment fails to get FDA approval, shares sink - Reuters

    Capricor's Duchenne treatment fails to get FDA approval, shares sink Reuters

Comments

Comments need JavaScript.